Crossmark

C-reactive protein- and clinical symptoms-guided strategy in term neonates with early-onset sepsis reduced antibiotic use and hospital stay: a quality improvement initiative

Crossref DOI link: https://doi.org/10.1186/s12887-020-02426-w

Published Online: 2020-11-20

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gyllensvärd, Johan http://orcid.org/0000-0002-8671-6346
Ingemansson, Fredrik

Hentz, Elisabet

Studahl, Marie

Elfvin, Anders
Funding

Funding for this research was provided by:

The Swedish state under an agreement between the Swedish government and the county council, the ALF-agreement. (117661)

Futurum - Akademin för Hälsa och Vård, Region Jönköpings läns
License Information

Text and Data Mining valid from 2020-11-20

Version of Record valid from 2020-11-20
More Information

Article History

Received: 19 May 2020

Accepted: 10 November 2020

First Online: 20 November 2020

Ethics approval and consent to participate

: The regional ethical committee of Linköping approved this study, dnr 2018/503–31. The committee did not require individual consent, because the clinical data were obtained in retrospect and no data which can identify a patient would be publicly available.

: All authors have given their consent for publication.

: The authors have no competing interest to declare.

Document is current

Any future updates will be listed below